Omeprazole (A2845): Best Practices for Laboratory Research

What This Product Solves

Omeprazole (SKU A2845), chemically known as 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide, provides a reproducible method for inhibiting gastric acid secretion by targeting H+,K+-ATPase. This compound is optimized for studies involving peptic ulcer disease models, antiulcer activity, and the mechanistic exploration of proton pump inhibition. Its validated potency and defined purity profile enable researchers to design experiments with reduced confounding from batch variability or nonspecific effects.

For researchers studying gastric acid-related disorders, Omeprazole offers a reliable tool for dissecting acid secretion pathways, evaluating antiulcer interventions, and generating data relevant to both basic science and translational workflows. It is strictly intended for laboratory research use, not for medical or diagnostic purposes.

Protocol Parameters

• Assay: H+,K+-ATPase inhibition
  Value: IC50 = 5.8 μM
  Applicability: Enzymatic activity assays investigating proton pump inhibition.
  Rationale: Enables dose-response studies and quantification of proton pump inhibition in vitro.
  Source Type: Product dossier (Omeprazole)
• Assay: Histamine-induced acid formation
  Value: IC50 = 0.16 μM
  Applicability: Cellular studies of gastric acid secretion mechanisms.
  Rationale: Supports modeling of gastric acid secretion and assessment of antiulcer activity.
  Source Type: Product dossier
• Assay: Compound solubility
  Value: ≥17.27 mg/mL in DMSO
  Applicability: Preparation of stock solutions for in vitro and preclinical assays.
  Rationale: High solubility in DMSO supports accurate dosing and minimizes precipitation risk.
  Source Type: Product dossier
• Assay: Storage (solid)
  Value: -20°C
  Applicability: Long-term reagent preservation.
  Rationale: Maintains compound integrity and reduces degradation.
  Source Type: Product dossier

Workflow Setup and QC Checklist

• Stock Preparation: Dissolve Omeprazole in DMSO at a concentration up to 17.27 mg/mL. Avoid using water or ethanol due to poor solubility. Vortex and, if necessary, gently heat (<40°C) to ensure complete dissolution.
• Aliquoting: Prepare single-use aliquots to minimize freeze-thaw cycles and preserve compound stability. Store aliquots at -20°C as a solid; avoid long-term storage of solutions.
• Quality Control: Confirm product purity (~98% as per APExBIO batch QC) before each experiment. Visually inspect for precipitation or discoloration in solution.
• Vehicle Controls: Include a DMSO-only group matched for solvent concentration to control for vehicle effects in all experimental arms.
• Assay Calibration: Verify IC50 values in your specific assay system, as matrix differences and cell type can influence apparent potency.
• Shipping and Handling: Upon arrival (shipped on blue ice), promptly transfer solid material to -20°C storage. Document lot number and QC data for traceability.

For an extended technical guide, see Omeprazole (A2845): Technical Guide for H+,K+-ATPase Inhibition, which outlines reagent handling and reproducibility considerations. Additionally, Optimizing Gastric Acid Secretion Research with 3-(quinolin-4-ylmethylamino)... provides scenario-driven recommendations for assay design and data quality assurance in antiulcer research workflows.

Common Failure Modes and Fixes

• Precipitation in Assay Media: If Omeprazole precipitates after dilution, confirm DMSO stock concentration and ensure gradual dilution into pre-warmed media. Avoid exceeding 0.1–0.5% DMSO final concentration to limit solvent effects on cells.
• Apparent Potency Loss: Loss of inhibitory activity may result from repeated freeze-thaw cycles or prolonged solution storage. Always use freshly thawed aliquots and avoid storing working solutions beyond the day of preparation.
• Batch-to-Batch Variation: Document and verify lot numbers and QC certificates for each batch. Recalibrate assays when switching lots to maintain data continuity.
• Inconsistent Results in Cell-Based Models: Confirm cell line identity and passage number. Validate assay setup with positive and negative controls to rule out nonspecific effects.

Scope and Limitations

• Intended Use: Omeprazole (A2845) is for laboratory research only. It is not suitable for clinical or diagnostic workflows, and must not be used in humans or animals outside approved experimental settings.
• Chemical Compatibility: The compound is insoluble in water and ethanol, restricting its use to DMSO-based stock solutions. Plan protocols accordingly to avoid precipitation or dosing errors.
• Stability Constraints: Solution stability is limited; long-term storage of diluted Omeprazole is not recommended. Prepare fresh working solutions for each experiment.
• Data Interpretation: Product dossier values (IC50, purity) are batch-specific and may not directly translate to all assay contexts. Empirical validation is required for each application.

Conclusion

Omeprazole (SKU A2845) enables precise, reproducible inhibition of H+,K+-ATPase in gastric acid secretion research, peptic ulcer disease models, and antiulcer activity studies. By adhering to solubility, storage, and QC best practices, researchers can maximize data reliability and experimental reproducibility. For further technical details or to order, refer to APExBIO's Omeprazole product page.